CALADRIUS BIOSCIENCES INC's ticker is CLBS and the CUSIP is 128058203. A total of 31 filers reported holding CALADRIUS BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $119,000 | +310.3% | 61,506 | +199.3% | 0.00% | – |
| Q4 2020 | $29,000 | -50.8% | 20,548 | -37.1% | 0.00% | – |
| Q3 2020 | $59,000 | -7.8% | 32,649 | -9.3% | 0.00% | – |
| Q2 2020 | $64,000 | -5.9% | 35,987 | -5.3% | 0.00% | – |
| Q1 2020 | $68,000 | -28.4% | 38,004 | 0.0% | 0.00% | – |
| Q4 2019 | $95,000 | -1.0% | 38,004 | 0.0% | 0.00% | – |
| Q3 2019 | $96,000 | +10.3% | 38,004 | 0.0% | 0.00% | – |
| Q2 2019 | $87,000 | -40.8% | 38,004 | -6.4% | 0.00% | – |
| Q1 2019 | $147,000 | +2.1% | 40,606 | +0.3% | 0.00% | – |
| Q4 2018 | $144,000 | -39.7% | 40,503 | 0.0% | 0.00% | – |
| Q3 2018 | $239,000 | -8.8% | 40,503 | 0.0% | 0.00% | – |
| Q2 2018 | $262,000 | +33.0% | 40,503 | +20.0% | 0.00% | – |
| Q1 2018 | $197,000 | +328.3% | 33,765 | +236.6% | 0.00% | – |
| Q3 2016 | $46,000 | – | 10,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 55,579 | $157,000 | 0.28% |
| Virtu KCG Holdings LLC | 20,790 | $59,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 20,913 | $59,000 | 0.00% |
| BlackRock Fund Advisors | 1,526 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 108,573 | $307,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 286 | $1,000 | 0.00% |
| Joel Isaacson & Co., LLC | 160 | $0 | 0.00% |
| UBS Group AG | 3,155 | $9,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 300 | $1,000 | 0.00% |
| IFP Advisors, Inc | 573 | $2,000 | 0.00% |